Achieving Health for All: The New Era of Collaboration and Innovation
Today, less than a decade away from the deadline to deliver the 2030 promise outlined in the Sustainable Development Goals (SDGs), universal access to quality healthcare and medical innovation remains a global challenge, with far too many people with either no access to healthcare at all or access to only very basic levels of it.
Moreover, the world is now facing unprecedented challenges to access to essential medicines and other health commodities, with the current crisis threatening decades of achievements, further delaying the world from meeting the targets outlined in SDG 3 and, in particular, Universal Health Coverage (UHC).
However, there are lessons that the global health community can take away from the COVID-19 pandemic, especially when it comes to the use of digital technologies and the role of digitalisation in high-, middle-, and low-income countries alike.
- How can the global health community improve access to healthcare and life-saving medicines for the most underserved populations?
- What is the role of innovation in this process?
- What does it mean in terms of achieving Health for All?
- Alan Donnelly, Executive Chairman, Sovereign Strategy, UK; Founder and Convenor of the G20 Health and Development Partnership
- Armin Fidler, Senior Lecturer, European Master of Health Economics, Management Center Innsbruck (MCI), Austria
- Lieve Fransen, Senior Policy Advisor, European Policy Centre, Belgium
- Sue Henshall, CEO, City Cancer Challenge Foundation, Switzerland
- Frédéric Thomas, Research Director, CNRS, France
- Padraic Ward, Head of Pharma International, Roche, Switzerland
- Andrew Jack, Editor, Financial Times, UK